BTMD
biote
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: BTMD
- PE Ratio
The current price-to-earnings ratio for biote stock as of Jun 3, 2026 is 4.31. This is calculated based on the current EPS of $0.49 and the stock price of $2.11 per share. The PE ratio has increased by 31% from the past four quarters average of 3.3.
BTMD PE ratio history
The average historical PE ratio of biote for the last five years is 14.46. The current price-to-earnings ratio of 4.31 is 70% less than the historical average. In the past five years, BTMD's PE ratio reached its highest point in the Dec 2024 quarter at 68.67, when the stock price was $6.18 and the EPS was $0.09. The lowest point was recorded in the Jun 2022 quarter, when it reached 0.09 with a price of $3.77 and an EPS of $42.19.
biote PE ratio by year
Maximum annual increase: 80.71% in 2024
Maximum annual decrease: -95.6% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 3.02 | -95.6% | $2.6 | $0.86 |
| 2024 | 68.67 | 80.71% | $6.18 | $0.09 |
| 2023 | 38 | N/A | $4.94 | $0.13 |
| 2022 | N/A | N/A | $3.73 | -$0.12 |
| 2021 | 0.29 | N/A | $9.8 | $33.29 |
| 2020 | N/A | N/A | N/A | $29.76 |
| 2019 | N/A | N/A | N/A | $21.73 |
biote PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 2.76 | -8.61% | $1.35 | $0.49 |
| Dec 2025 | 3.02 | -8.48% | $2.6 | $0.86 |
| Sep 2025 | 3.3 | -18.72% | $3 | $0.91 |
| Jun 2025 | 4.06 | -17.14% | $4.02 | $0.99 |
| Mar 2025 | 4.9 | -92.86% | $3.33 | $0.68 |
| Dec 2024 | 68.67 | 306.09% | $6.18 | $0.09 |
| Sep 2024 | 16.91 | -45.68% | $5.58 | $0.33 |
| Jun 2024 | 31.13 | 7.34% | $7.47 | $0.24 |
| Mar 2024 | 29 | -23.68% | $5.8 | $0.2 |
| Dec 2023 | 38 | N/A | $4.94 | $0.13 |
| Sep 2023 | N/A | N/A | $5.12 | -$0.17 |
| Jun 2023 | N/A | N/A | $6.76 | -$0.42 |
| Mar 2023 | N/A | N/A | $6.19 | -$0.51 |
| Dec 2022 | N/A | N/A | $3.73 | -$0.12 |
| Sep 2022 | 0.1 | 11.11% | $4.28 | $42.11 |
BTMD Price vs fair value
BTMD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, BTMD's PE ratio is lower than the 3 and 5-year averages.
PE comparison
With a P/E of 4.31, BTMD stands below the Healthcare sector and the industry average. Looking at its Healthcare sector average of 23.02, biote's P/E is 81% lower.
BTMD PE vs peers
BTMD's PE ratio is above its peer stock HERE.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HERE Here Group Ltd. | 2.18 | $128.69M |
| BTMD biote Corp | 4.84 | $89.07M |
Frequently asked questions
What is biote's PE ratio?
BTMD stock has a price to earnings ratio of 4.31 as of Jun 3, 2026.
What is the 3-year average PE ratio for biote (BTMD)?
The average PE ratio for BTMD stock over the past 3 years is 20.18.
What is the 5-year average PE ratio for biote (BTMD)?
The average PE ratio for BTMD stock over the past 5 years is 14.46.
What is the highest PE ratio for BTMD?
In the last five years, the Dec 2024 quarter recorded the highest quarterly PE ratio at 68.67.
How does the current PE ratio for BTMD compare to its historical average?
The current price to earnings ratio of BTMD is 70% lower than the 5-year historical average.
Why is biote's PE ratio so low?
BTMD's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
How is BTMD's PE ratio calculated (biote PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 3, 2026), biote's stock price is $2.11. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.49. Therefore, biote's price to earnings ratio for today is 4.31. PE RATIO(4.31) = STOCK PRICE($2.11) / TTM EPS($0.49)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.